Hi Grainsfsand,
An interesting point is that while Amylyx was running up $US381 Million in sales, 43%of patients were discontinuing it's use due to side effects. So $US500 million would probably be closer in the first year.
Also@Densy posted a nice table recently showing the average MC of a bio company Vs sales. 8.3 I think it was.
Cheers
Hi Grainsfsand, An interesting point is that while Amylyx was...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.69M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.3¢ | $108.2K | 647.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 109170 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 117939 | 4 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |